Scientific advisers to the C.D.C. have been discussing the details of federal guidance on who qualifies for a Pfizer-BioNTech booster shot and why. A decision is expected on Thursday.
source https://www.nytimes.com/2021/09/23/health/pfizer-booster-cdc-fda-authorize.html
0 Comments